norfloxacin has been researched along with Abscess, Pulmonary in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pefloxacin was used to treat nosocomial pulmonary infections in 46 mechanically ventilated patients." | 1.27 | Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients. ( Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, C | 1 |
| Gouin, F | 1 |
| Fourrier, F | 1 |
| Junginger, W | 1 |
| Prieur, BL | 1 |
1 other study available for norfloxacin and Abscess, Pulmonary
| Article | Year |
|---|---|
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Midd | 1988 |